SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPod Point Regulatory News (PODP)

  • There is currently no data for PODP

Trading Statement

21 Nov 2022 07:00

RNS Number : 9867G
Pod Point Group Holdings PLC
21 November 2022
 

21 November 2022

 

Pod Point Group Holdings plc

(the "Group")

 

Trading update

The long-term market for Plug-In-vehicles (PIVs) continues to be attractive as the industry grows towards electrification in the UK by 2030.

However, growth in the second half of 2022 has slowed markedly, which has been driven by supply chain challenges in car manufacturing causing reduced deliveries into the UK. Automotive companies continue to report long lead times for customers wishing to place orders.

SMMT data demonstrates that the growth rate of PIVs from 2020 to 2021 was 76% year on year. The growth of PIVs in the first half of 2022 of 26% has since slowed to 7% in the four months to 31st October 2022. These continued trends indicate the total market for PIVs will be circa 350,000 in 2022 and circa 375,000 in 2023.

As noted in the interim results, our first half 2022 market share in the Home segment (calculated as number of Home installs divided by new PIV registrations) benefitted from customers scheduling their installs in advance of vehicle delivery ahead of the cessation of the Government funded OZEV home grant on 31 March 2022. This scheduling change remains a factor in the current market, and allowing for this, we expect full year market share in the Home segment to stabilise around our long term historical share.

As a result of these challenges the Group expects full year 2022 revenues to be approximately £70m with an adjusted EBITDA loss of circa £7m.

The Group continues to benefit from a strong balance sheet with year-end cash expected to be in excess of £70 million in line with guidance provided at H1.

2023 outlook

Whilst it is today difficult to predict the outcome for 2023, we are prudently assuming that these supply chain and macroeconomic issues extend into 2023, and thus the Group expects full year revenues for 2023 to be in the region of £85 to £90m.

This reduction in revenues will impact adjusted EBITDA, delivering a mid-single digital adjusted EBITDA loss in 2023.

The Group is expected to maintain a strong balance sheet and to end 2023 with around £50 million of cash, after required investment. We will continue to invest in hardware and software development to drive revenue growth, combined with further investment in Owned Assets at a targeted and limited level.

In the longer term, the Group expects the UK to return to rapid growth in PIV registrations as the supply chain restrictions and general economy recover. We fully expect the UK to achieve its goal of banning new internal combustion engine cars by 2030, and hence foresee strong growth in demand for charging infrastructure over the next decade and beyond.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Group's obligations under Article 17 of MAR.

 

ENDS

 

Enquiries: 

Tulchan (Public Relations adviser to Pod Point)

James Macey White/ Mark Burgess/ Matt Low/ Arthur Rogers

+44 (0)20 7353 4200 / PodPoint@tulchangroup.com

BofA Securities (Joint Corporate broker)

Peter Luck, Marcus Jackson, Mitchell Evans

+44 (0)20 7628 1000

Numis (Joint Corporate broker)

Andrew Coates

 

+44 (0)20 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZMZMMGVGZZZ
Date   Source Headline
27th Sep 20224:36 pmRNSPrice Monitoring Extension
2nd Sep 20227:00 amRNSExercise of Options and Issue of New Shares
16th Aug 20227:00 amRNSDirector/PDMR Shareholding
28th Jul 20227:00 amRNSHalf-year Report
30th Jun 20227:00 amRNSCFO Designate Appointment
10th Jun 20223:00 pmRNSSecond Manufacturer Contract
8th Jun 20226:30 pmRNSBlock listing Interim Review
27th May 20224:36 pmRNSPrice Monitoring Extension
9th May 20225:45 pmRNSPublication of Annual Financial Report (updated)
9th May 20224:43 pmRNSPublication of Annual Financial Report
4th May 20222:28 pmRNSDirector Declaration
11th Apr 202212:05 pmRNSNew Contract Win
14th Mar 20224:30 pmRNSDirector/PDMR Shareholding
11th Mar 20225:25 pmRNSDirector Declaration
21st Feb 20229:00 amRNSEstablishment of new ESG Committee
18th Feb 20227:00 amRNSPreliminary Unaudited Results for FY2021
6th Jan 20227:00 amRNSTrading Update and Notice of Results
4th Jan 202211:00 amRNSTotal Voting Rights
20th Dec 20215:30 pmRNSDirector Declaration
20th Dec 20214:00 pmRNSAppointment of Joint Corporate Brokers
3rd Dec 20216:33 pmRNSExercise of Over-allotment Option
3rd Dec 20214:57 pmRNSPost-Stabilisation Period Announcement
3rd Dec 20212:15 pmRNSBlock Listing Application
1st Dec 202110:06 amRNSTotal Voting Rights
25th Nov 20214:13 pmRNSNew Contract Win
16th Nov 202111:57 amRNSHolding(s) in Company - Replacement
12th Nov 20217:00 amRNSMid-stabilisation Period Announcement
11th Nov 20214:38 pmRNSHolding(s) in Company
9th Nov 20217:21 amRNSAdmission to Trading on the London Stock Exchange
4th Nov 20211:51 pmRNSApproval and Publication of Prospectus
4th Nov 20217:00 amRNSPre-Stabilisation Period Notice
4th Nov 20217:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.